Table 1.
Correlation between AC099850.3 expression and clinicopathologic features in the TCGA-LUAD cohort.
| Characteristic | Low expression of AC099850.3 | High expression of AC099850.3 | p |
|---|---|---|---|
| n | 267 | 268 | |
| T stage, n (%) | 0.032 | ||
| T1 | 102 (19.2%) | 73 (13.7%) | |
| T2 | 129 (24.2%) | 160 (30.1%) | |
| T3 | 26 (4.9%) | 23 (4.3%) | |
| T4 | 8 (1.5%) | 11 (2.1%) | |
| N stage, n (%) | 0.001 | ||
| N0 | 191 (36.8%) | 157 (30.3%) | |
| N1 | 37 (7.1%) | 58 (11.2%) | |
| N2 | 26 (5%) | 48 (9.2%) | |
| N3 | 1 (0.2%) | 1 (0.2%) | |
| M stage, n (%) | 0.013 | ||
| M0 | 179 (46.4%) | 182 (47.2%) | |
| M1 | 8 (2.1%) | 17 (4.4%) | |
| Age, meidan (IQR) | 67 (60, 73.75) | 65 (58, 72) | 0.053 |